Target intelligence / Profile preview

Glutamate receptor ionotropic, NMDA 1 (GluN1) subunit N-terminal domain (GluN1 NTD)

Target
GluN1 NTD
Molecular classification
Ion channel, Glutamate receptor, Ligand-gated ion channel
01

Overview

The GluN1 subunit N-terminal domain (NTD) is a distinct structural region of the obligatory GluN1 subunit within the N-methyl-D-aspartate (NMDA) receptor complex. As a member of the ionotropic glutamate receptor family, the NMDA receptor plays a fundamental role in excitatory synaptic transmission, neurodevelopment, and synaptic plasticity mechanisms like long-term potentiation (LTP) [PubMed: 24560577]. The GluN1 NTD functions as a sophisticated allosteric signaling hub, where the binding of various modulators—including polyamines, protons, and certain ions—regulates the receptor's gating kinetics and ion channel open probability [PubMed: 21460830]. Clinically, this domain is of paramount importance as the primary epitope for pathogenic autoantibodies in anti-NMDA receptor encephalitis, a condition characterized by the depletion of surface receptors and subsequent neuropsychiatric dysfunction [PubMed: 20871601]. Furthermore, the GluN1 NTD is a target for pharmacological intervention, as small molecules and antibodies modulating this domain are being explored for treating conditions ranging from schizophrenia to neurodegenerative disorders [PubMed: 28973445]. By serving as a site for subunit-specific allosteric control, the GluN1 NTD offers a unique pathway for fine-tuning NMDA receptor activity without the global blockade associated with pore-binding antagonists.

Other names
GRIN1 NTDNMDA receptor subunit 1 N-terminal domainNR1 NTDGlutamate [NMDA] receptor subunit zeta-1 NTDGluN1 amino-terminal domain
02

Mechanism of action

Allosteric modulation of the NMDA receptor; the NTD acts as a regulatory domain that, upon ligand binding, influences the opening frequency and duration of the ion channel pore [PubMed: 24560577].

03

Biological functions

Synaptic plasticityExcitatory neurotransmissionLearning and memoryReceptor assemblyAllosteric regulation
04

Disease associations

Anti-NMDA receptor encephalitisSchizophreniaEpilepsyAlzheimer's diseaseStrokeChronic pain
05

Safety considerations

Psychotomimetic effectsCognitive impairmentExcitotoxicitySeizure risk
06

Interacting drugs

Ifenprodil

5 more in the full profile.

07

Biomarkers

Anti-GluN1 IgG antibodiesGRIN1 genetic variants

Beyond the preview

Go deeper on Glutamate receptor ionotropic, NMDA 1 (GluN1) subunit N-terminal domain (GluN1 NTD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor ionotropic, NMDA 1 (GluN1) subunit N-terminal domain (GluN1 NTD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call